| 摘要 |
PC 7628 A pharmaceutical preparation for parenteral administration of a drug consisting of a solvent system containing: (a) 0 to 65% by weight of .alpha.-tetrahydrofurfuryl-.omega.- hydroxy-polyloxyethylene; (b) 10 to 100% by weight polyethylene glycol with a mean molecular weight of 200 to 600; and (c) 0 to 35% by weight of water The sum of components (a) and (b) amounting to at least 65% by weight, and one or more therapeutically active compounds of the formula (I) wherein R1 denotes a phenyl radical optionally substituted with 1 to 3 substituents independently selected from the group consisting of F, Cl, Br, I, CF3, Cl to C4 alkyl, and C1 to C4 alkoxy, or 5-chloro-pyrid-2-yl; X denotes OH, F, Cl or Br; R2 is H, CH3 or F; and R3 is H or F.
|
